Precision BioSciences Valuation
| DTIL Stock | USD 10.23 0.55 5.68% |
At this time, the company appears to be overvalued. Precision BioSciences holds a recent Real Value of $6.45 per share. The prevailing price of the company is $10.23. Our model determines the value of Precision BioSciences from analyzing the company fundamentals such as Return On Equity of -1.07, operating margin of (2.12) %, and Shares Outstanding of 6.92 M as well as examining its technical indicators and probability of bankruptcy. In general, most investors support picking up undervalued entities and discarding overvalued entities since, at some point, asset prices and their ongoing real values will merge together. Key fundamental drivers impacting Precision BioSciences' valuation include:
Price Book 5.1777 | Enterprise Value -18.5 M | Enterprise Value Ebitda (0.38) | Price Sales 2.0042 | Enterprise Value Revenue 0.2513 |
Overvalued
Today
Please note that Precision BioSciences' price fluctuation is unstable at this time. Calculation of the real value of Precision BioSciences is based on 3 months time horizon. Increasing Precision BioSciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Precision BioSciences is useful when determining the fair value of the Precision stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Precision BioSciences. Since Precision BioSciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Precision Stock. However, Precision BioSciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 10.23 | Real 6.45 | Target 3.07 | Hype 10.32 |
The real value of Precision Stock, also known as its intrinsic value, is the underlying worth of Precision BioSciences Company, which is reflected in its stock price. It is based on Precision BioSciences' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Precision BioSciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Precision BioSciences' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Precision BioSciences helps investors to forecast how Precision stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Precision BioSciences more accurately as focusing exclusively on Precision BioSciences' fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Precision BioSciences' intrinsic value based on its ongoing forecasts of Precision BioSciences' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Precision BioSciences' closest peers. When choosing an evaluation method for Precision BioSciences, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Precision BioSciences Investments |
|
Precision Valuation Trend
Knowing Precision BioSciences' actual value is paramount for traders to make sound investment determinations. Precision BioSciences' real value is not only important for the investor to make better decisions but also for a more accurate overall view of Precision BioSciences' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Precision BioSciences' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Precision Market Cap
Precision BioSciences is rated below average in market capitalization category among related companies. Market capitalization of Health Care industry is currently estimated at about 20.23 Billion. Precision BioSciences adds roughly 66.95 Million in market capitalization claiming only tiny portion of equities under Health Care industry.Precision BioSciences Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Precision BioSciences's current stock value. Our valuation model uses many indicators to compare Precision BioSciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Precision BioSciences competition to find correlations between indicators driving Precision BioSciences's intrinsic value. More Info.Precision BioSciences is rated below average in price to earning category among related companies. It is rated # 5 in price to book category among related companies . Price To Book Ratio is expected to rise to 2.34 this year. Comparative valuation analysis is a catch-all model that can be used if you cannot value Precision BioSciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Precision BioSciences' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Precision BioSciences' earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Precision BioSciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Precision BioSciences and how it compares across the competition.
About Precision BioSciences Valuation
The stock valuation mechanism determines the current worth of Precision BioSciences on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Precision BioSciences. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Precision BioSciences based exclusively on its fundamental and basic technical indicators. By analyzing Precision BioSciences's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Precision BioSciences's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Precision BioSciences. We calculate exposure to Precision BioSciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Precision BioSciences's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 40.5 M | 33.4 M | |
| Pretax Profit Margin | (0.87) | (0.92) | |
| Operating Profit Margin | (0.90) | (0.94) | |
| Net Loss | (1.43) | (1.50) | |
| Gross Profit Margin | 0.83 | 0.59 |
8 Steps to conduct Precision BioSciences' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Precision BioSciences' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Precision BioSciences' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Precision BioSciences' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Precision BioSciences' revenue streams: Identify Precision BioSciences' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Precision BioSciences' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Precision BioSciences' growth potential: Evaluate Precision BioSciences' management, business model, and growth potential.
- Determine Precision BioSciences' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Precision BioSciences' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Precision BioSciences Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Precision BioSciences does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 3.8 M |
Precision BioSciences Current Valuation Indicators
Valuation refers to the process of determining the present value of Precision BioSciences and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Precision we look at many different elements of the entity such as Precision's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Precision BioSciences' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Precision BioSciences' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Precision BioSciences, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Precision BioSciences' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Precision BioSciences' worth.When determining whether Precision BioSciences is a strong investment it is important to analyze Precision BioSciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Precision BioSciences' future performance. For an informed investment choice regarding Precision Stock, refer to the following important reports: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Precision BioSciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Precision Stock please use our How to buy in Precision Stock guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Complementary Tools for Precision Stock analysis
When running Precision BioSciences' price analysis, check to measure Precision BioSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Precision BioSciences is operating at the current time. Most of Precision BioSciences' value examination focuses on studying past and present price action to predict the probability of Precision BioSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Precision BioSciences' price. Additionally, you may evaluate how the addition of Precision BioSciences to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Global Correlations Find global opportunities by holding instruments from different markets |
Is Precision BioSciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precision BioSciences. If investors know Precision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Precision BioSciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (332.12) | Revenue Per Share 12.685 | Quarterly Revenue Growth (0.34) | Return On Assets (0.14) | Return On Equity (1.07) |
The market value of Precision BioSciences is measured differently than its book value, which is the value of Precision that is recorded on the company's balance sheet. Investors also form their own opinion of Precision BioSciences' value that differs from its market value or its book value, called intrinsic value, which is Precision BioSciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Precision BioSciences' market value can be influenced by many factors that don't directly affect Precision BioSciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Precision BioSciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Precision BioSciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Precision BioSciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.